Lilly(Eli) & Co (NYSE: LLY) kicked off on Friday, down -3.16% from the previous trading day, before settling in for the closing price of $871.86. Over the past 52 weeks, LLY has traded in a range of $711.40-$972.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 15.54%. While this was happening, its average annual earnings per share was recorded 76.38%. With a float of $850.44 million, this company’s outstanding shares have now reached $949.32 million.
Considering the fact that the conglomerate employs 43000 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 81.62%, operating margin of 36.65%, and the pretax margin is 28.15%.
Lilly(Eli) & Co (LLY) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – General Industry. The insider ownership of Lilly(Eli) & Co is 10.38%, while institutional ownership is 72.81%. The most recent insider transaction that took place on Feb 13 ’25, was worth 31,175,396. In this transaction 10% Owner of this company sold 35,446 shares at a rate of $879.52, taking the stock ownership to the 96,646,532 shares. Before that another transaction happened on Feb 13 ’25, when Company’s 10% Owner proposed sale 220,000 for $872.97, making the entire transaction worth $192,053,400.
Lilly(Eli) & Co (LLY) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 5.49 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 76.38% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 40.67% during the next five years compared to 18.77% growth over the previous five years of trading.
Lilly(Eli) & Co (NYSE: LLY) Trading Performance Indicators
Take a look at Lilly(Eli) & Co’s (LLY) current performance indicators. Last quarter, stock had a quick ratio of 0.97. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 17.79. Likewise, its price to free cash flow for the trailing twelve months is 572.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 11.72, a number that is poised to hit 4.71 in the next quarter and is forecasted to reach 29.13 in one year’s time.
Technical Analysis of Lilly(Eli) & Co (LLY)
Compared to the last year’s volume of 3.79 million, its volume of 2.65 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 69.09%. Additionally, its Average True Range was 22.63.
During the past 100 days, Lilly(Eli) & Co’s (LLY) raw stochastic average was set at 58.30%, which indicates a significant increase from 50.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 26.14% in the past 14 days, which was lower than the 31.46% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $798.74, while its 200-day Moving Average is $846.24. Nevertheless, the first resistance level for the watch stands at $864.68 in the near term. At $885.10, the stock is likely to face the second major resistance level. The third major resistance level sits at $896.69. If the price goes on to break the first support level at $832.67, it is likely to go to the next support level at $821.08. Should the price break the second support level, the third support level stands at $800.66.
Lilly(Eli) & Co (NYSE: LLY) Key Stats
The company with the Market Capitalisation of 801.48 billion has total of 949,316K Shares Outstanding. Its annual sales at the moment are 45,043 M in contrast with the sum of 10,590 M annual income. Company’s last quarter sales were recorded 13,533 M and last quarter income was 4,410 M.
